Press release
Glomerulonephritis Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Glomerulonephritis Market Analysis
What Is the Expected Glomerulonephritis Market Size During the Forecast Period?
In recent years, the market size of glomerulonephritis has shown appreciable growth. It is predicted to escalate from $11.06 billion in 2024 to $11.64 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the historic period include the increasing occurrence of kidney-related disorders, the prevalence of infections such as post-streptococcal glomerulonephritis, advancements in research and development, rising incidences of kidney failure, and heightened awareness about kidney diseases.
Robust expansion is anticipated in the glomerulonephritis market in the coming years, with projections estimating it to reach $14.14 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected growth during the forecast period can be linked to a rise in diabetes cases, an aging demographic, an upswing in healthcare investments, a surge in the dialysis patient count, and an increase in autoimmune disease instances. The forecast period is also expected to witness key trends such as the inception of novel treatments and therapies, advancements in diagnostic technology, new therapeutic methods, partnership among companies, and the utilization of intravenous immunoglobulin therapy.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21193
What Are the High-Growth Segments in the Glomerulonephritis Market?
The glomerulonephritis market covered in this report is segmented -
1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis
2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis
3) By Treatment: Medication, Surgery, Dialysis, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome
2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21193&type=smp
What Key Drivers Are Expected to Influence Future Glomerulonephritis Market Growth?
An increase in kidney disorders is expected to boost the glomerulonephritis market's growth. These conditions, which can disrupt the kidneys' structure or functioning, result in ineffective filtration, waste elimination, and fluid balance. Contributing factors to the increase in kidney disorders include aging populations, soaring incidences of chronic illnesses like diabetes and hypertension, and certain lifestyle decisions. Kidney disorders can lead to glomerulonephritis through the effects they have on immune system functionality, chronic inflammation, or structural damage, all causing dysfunction in kidney filtration and operation. Illustratively, the Australian Institute of Health and Welfare reported in December 2024 that mortality rates due to chronic kidney disease (CKD) surged by 4.2% in 2021 and 6.2% in 2022. During 2021-22, approximately 2 million hospital admissions were related to CKD, accounting for 18% of all hospitalizations in Australia. Hence, the escalating incidence of kidney disorders is likely to fuel the expansion of the glomerulonephritis market.
Which Companies Hold the Largest Share Across Different Glomerulonephritis Market Segments?
Major companies operating in the glomerulonephritis market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Asahi Kasei Medical Co. Ltd., Boehringer Ingelheim International GmbH, DaVita Inc., Biogen Inc., Merit Medical Systems Inc., Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., NovelMed Therapeutics Inc.
What Glomerulonephritis Market Trends Are Gaining Traction Across Different Segments?
Leading firms in the glomerulonephritis market are concentrating their efforts on creating advanced non-immunosuppressive treatments to fulfill unmet medical requirements and enhance patients' outcomes. Non-immunosuppressive therapies, which are designed not to suppress or impair the immune system, aim to provide treatments without undermining immune functionality. For example, in September 2024, Travere Therapeutics Inc., a biopharmaceutical company based in the US, launched FILSPARI (sparsentan). This treatment received approval from the Food and Drug Administration (FDA) for its efficacy in treating IgA nephropathy, a type of kidney disease. FILSPARI is notable for being the only non-immunosuppressive action found to significantly reduce the deterioration of kidney function in this patient group. Its approval represents a significant step forward in the treatment of IgA nephropathy, the most widespread type of primary glomerulonephritis. FILSPARI presents a novel treatment alternative for patients who previously had little choice, echoing Travere's dedication to advancing patient results in kidney disease.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/glomerulonephritis-global-market-report
What Are the Emerging Geographies for The Glomerulonephritis Market Growth?
North America was the largest region in the glomerulonephritis market in 2024. The regions covered in the glomerulonephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Glomerulonephritis Market?
2. What is the CAGR expected in the Glomerulonephritis Market?
3. What Are the Key Innovations Transforming the Glomerulonephritis Industry?
4. Which Region Is Leading the Glomerulonephritis Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glomerulonephritis Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here
News-ID: 4069953 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Glomerulonephritis
Glomerulonephritis Market: An In-Depth Analysis
Glomerulonephritis is a condition affecting the kidneys, specifically the glomeruli, which are small blood vessels responsible for filtering waste from the blood. When these glomeruli become inflamed, it can lead to impaired kidney function. Glomerulonephritis can be caused by infections, autoimmune diseases, or other underlying health conditions. Its significance lies in its potential to cause chronic kidney disease (CKD) or end-stage renal failure if left untreated. With an increasing prevalence…
Glomerulonephritis Treatment Market Size, Share, Industry, Forecast and outlook …
Glomerulonephritis Treatment Market
Glomerulonephritis Treatment Market Poised for Growth, Expected to Reach 5.4% CAGR by 2031
The global Glomerulonephritis Treatment Market is set to exhibit a robust growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period from 2024 to 2031.
Glomerulonephritis, also known as Bright's disease, is a progressive kidney ailment characterized by the impairment of glomeruli, the kidney's filtering units responsible for eliminating waste through…
Glomerulonephritis Market to Grasp Outstanding CAGR of 4.70% by 2029
The glomerulonephritis market is expected to witness market growth at a rate of 4.70% in the forecast period of 2022 to 2029. Data Bridge Market Research report on glomerulonephritis market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in healthcare sector globally is escalating the growth of glomerulonephritis market.
Get Full Report: https://www.databridgemarketresearch.com/reports/global-glomerulonephritis-market
Glomerulonephritis…
Glomerulonephritis Treatment Market Set for Rapid Growth And Trend, by 2028
Glomerulonephritis Treatment Market: Introduction
Glomerulonephritis, also known as Bright's disease, is a progressive kidney disease that damages the glomeruli—the filtering units of the kidney that create urine as a waste. There are two types of glomerulonephritis, namely acute glomerulonephritis and chronic glomerulonephritis. The acute glomerulonephritis disease develops suddenly and can be caused by infections, such as strep throat. Acute glomerulonephritis disease can also be caused by infection in the throat or…
Glomerulonephritis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Glomerulonephritis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis - Pipeline Review, H1 2017, provides an overview of the Interstitial Cystitis (Genito Urinary System And Sex Hormones) pipeline landscape.
Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience…
Pipeline Analysis on Glomerulonephritis Reviewed by Company, Profiled Drugs and …
According to a latest pipeline assessment on the Glomerulonephritis, it has been analysed that the main factors that result in glomerulonephritis are family history, strep throat, immune diseases, such as lupus, type 1 & type 2 diabetes and viruses, such as hepatitis B virus, HIV and hepatitis C virus. The rapid increase in these factors has directly augmented the glomerulonephritis disease. Recently, a detailed analysis has been added to Market…
